Identifying Optimal Vaccination Strategies for Serogroup A Neisseria meningitidis Conjugate Vaccine in the African Meningitis Belt

Baseline Meningococcal Carriage in Burkina Faso before the Introduction of a Meningococcal Serogroup A Conjugate Vaccine

(2011) Paul A. Kristiansen et al.   Clinical and Vaccine Immunology

Immunogenicity and Safety of a Meningococcal A Conjugate Vaccine in Africans

(2011) Samba O. Sow et al.   NEW ENGLAND JOURNAL OF MEDICINE

Antibody Persistence after Serogroup C Meningococcal Conjugate Immunization of United Kingdom Primary‐School Children in 1999–2000 and Response to a Booster: A Phase 4 Clinical Trial

(2010) K. P. Perrett et al.   CLINICAL INFECTIOUS DISEASES

Kinetics of Antibody Persistence following Administration of a Combination Meningococcal Serogroup C and Haemophilus influenzae Type b Conjugate Vaccine in Healthy Infants in the United Kingdom Primed with a Monovalent Meningococcal Serogroup C Vaccine

(2009) R. Borrow et al.   Clinical and Vaccine Immunology

A hypothetical explanatory model for meningococcal meningitis in the African meningitis belt

(2009) Judith E. Mueller et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Bactericidal antibody is the immunologic surrogate of protection against meningococcal disease

(2009) Carl E. Frasch et al.   VACCINE

Determinants of vaccination coverage in rural Nigeria

(2008) Olumuyiwa O Odusanya et al.   BMC PUBLIC HEALTH

Impact of Meningococcal Serogroup C Conjugate Vaccines on Carriage and Herd Immunity

(2008) Martin C. J. Maiden et al.   JOURNAL OF INFECTIOUS DISEASES

INFECTIOUS DISEASE: An Ill Wind, Bringing Meningitis

(2008) L. Roberts   SCIENCE